Tibet Weixinkang Medicine is a comprehensive high-tech pharmaceutical company that focuses on research, development, production, and sales of medical products. Established in 2006 and listed on the Shanghai Stock Exchange in 2017, the company has 11 subsidiaries spread across Beijing, Tibet, Inner Mongolia, Hainan, Jiangsu, and Hong Kong, employing nearly 800 people. With a clinical-oriented approach and a commitment to innovation, Tibet Weixinkang Medicine excels in the field of intravenous vitamins, trace elements, and electrolytes.

As experts in adult and pediatric parenteral nutrition therapy, their leading products include a wide range of injectable vitamins, amino acids, micronutrients, and electrolytes. Supported by a research and development center with nearly 200 staff members, the company has achieved significant progress in pharmaceutical technology. They have obtained 14 invention patents, 17 new drug certificates, and 17 registration approvals.

Moreover, they have established a strong market presence, covering over 3,000 medical institutions nationwide and offering customized commercial solutions. Tibet Weixinkang Medicine strives to fulfill their mission of caring for life and maintaining health. They aim to become a respected and leading innovative pharmaceutical enterprise, contributing to the modernization and scaling of the healthcare industry while providing accessible treatment solutions